🇺🇸 FDA
Patent

US 10702590

Compositions and methods for treating thyroid disease

granted A61KA61K31/593A61K33/04

Quick answer

US patent 10702590 (Compositions and methods for treating thyroid disease) held by Script Essentials, LLC expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Script Essentials, LLC
Grant date
Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/593, A61K33/04, A61K38/063, A61K38/44